3
Announcements
Trials
Browse
Landscape
Phase
Phase 4
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Lymphoid
1
Conditions
Wounds and Injuries
1
Peripheral Nervous System Diseases
1
Neuralgia
1
Lymphoma, Follicular
1
Bronchiolitis Obliterans Syndrome
1
Interventions
Cyclophosphamide
27
Vincristine
24
Dexamethasone
22
Rituximab
21
Methotrexate
21
Cytarabine
21
Mercaptopurine
16
Doxorubicin
15
Etoposide
13
Asparaginase
13
Daunorubicin
12
Prednisone
10
Prednisolone
10
Granulocyte Colony-Stimulating Factor
10
Ifosfamide
8
Idarubicin
8
fludarabine
7
pegylated granulocyte colony-stimulating factor
6
Thioguanine
6
Teniposide
6
Vindesine
5
Brentuximab Vedotin
5
ibrutinib
4
fludarabine phosphate
4
Stem Cell Transplantation
4
Gemcitabine
4
Cisplatin
4
Aprepitant
4
zanubrutinib
3
prednylidene
3
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 4
×
ziconotide
×
Lymphoid
×
Clear all
NCT01373983
2014-12-30
ZicBol
University Hospital, Linkoeping
Phase 4
Completed
26 enrolled